z-logo
open-access-imgOpen Access
Candidemia in Patients with Ventricular Assist Devices
Author(s) -
Shmuel Shoham,
Robyn K. Shaffer,
L. Sweet,
Roger Cooke,
Nancy Donegan,
Steven W. Boyce
Publication year - 2006
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/509640
Subject(s) - medicine , candida parapsilosis , candida albicans , ventricular assist device , fungemia , mortality rate , intensive care medicine , mycosis , surgery , antifungal , microbiology and biotechnology , dermatology , heart failure , biology
During the period 1998-2004, candidemia developed in 7 of 117 ventricular assist device recipients at our hospital, and the associated mortality rate was 71%. Five cases of candidemia were due to Candida parapsilosis, and 2 were due to Candida albicans. Three of the 7 patients with ventricular assist device-associated Candida bloodstream infections were cured, and the device was retained in 2 of the 3 patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom